Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Formulation and optimization of raloxifene-loaded solid lipid nanoparticles to enhance oral bioavailability.

Tran TH, Ramasamy T, Cho HJ, Kim YI, Poudel BK, Choi HG, Yong CS, Kim JO.

J Nanosci Nanotechnol. 2014 Jul;14(7):4820-31.

PMID:
24757949
[PubMed - indexed for MEDLINE]
2.

Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.

Tran TH, Poudel BK, Marasini N, Chi SC, Choi HG, Yong CS, Kim JO.

Int J Pharm. 2013 Feb 25;443(1-2):50-7. doi: 10.1016/j.ijpharm.2013.01.013. Epub 2013 Jan 11.

PMID:
23318367
[PubMed - indexed for MEDLINE]
3.

Development and evaluation of solid lipid nanoparticles of raloxifene hydrochloride for enhanced bioavailability.

Kushwaha AK, Vuddanda PR, Karunanidhi P, Singh SK, Singh S.

Biomed Res Int. 2013;2013:584549. doi: 10.1155/2013/584549. Epub 2013 Oct 20.

PMID:
24228255
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique.

Tran TH, Poudel BK, Marasini N, Woo JS, Choi HG, Yong CS, Kim JO.

Arch Pharm Res. 2013 Jan;36(1):86-93. doi: 10.1007/s12272-013-0012-y.

PMID:
23325488
[PubMed - indexed for MEDLINE]
5.

Preparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticles.

Hu L, Xing Q, Meng J, Shang C.

AAPS PharmSciTech. 2010 Jun;11(2):582-7. doi: 10.1208/s12249-010-9410-3. Epub 2010 Mar 30.

PMID:
20352534
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.

Dong Z, Xie S, Zhu L, Wang Y, Wang X, Zhou W.

Drug Deliv. 2011 Aug;18(6):441-50. doi: 10.3109/10717544.2011.577109. Epub 2011 May 10.

PMID:
21554156
[PubMed - indexed for MEDLINE]
7.

In vivo and cytotoxicity evaluation of repaglinide-loaded binary solid lipid nanoparticles after oral administration to rats.

Rawat MK, Jain A, Singh S.

J Pharm Sci. 2011 Jun;100(6):2406-17. doi: 10.1002/jps.22454. Epub 2011 Jan 5.

PMID:
21491451
[PubMed - indexed for MEDLINE]
8.

Surface stabilized efavirenz nanoparticles for oral bioavailability enhancement.

Jain S, Sharma JM, Agrawal AK, Mahajan RR.

J Biomed Nanotechnol. 2013 Nov;9(11):1862-74.

PMID:
24059085
[PubMed - indexed for MEDLINE]
9.

Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.

Venishetty VK, Chede R, Komuravelli R, Adepu L, Sistla R, Diwan PV.

Colloids Surf B Biointerfaces. 2012 Jun 15;95:1-9. doi: 10.1016/j.colsurfb.2012.01.001. Epub 2012 Feb 14.

PMID:
22463845
[PubMed - indexed for MEDLINE]
10.

Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation.

Zhao L, Wei Y, Huang Y, He B, Zhou Y, Fu J.

Int J Nanomedicine. 2013;8:3769-79. doi: 10.2147/IJN.S51578. Epub 2013 Oct 2.

PMID:
24124365
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Improving oral absorption of Salmon calcitonin by trimyristin lipid nanoparticles.

Martins S, Silva AC, Ferreira DC, Souto EB.

J Biomed Nanotechnol. 2009 Feb;5(1):76-83.

PMID:
20055109
[PubMed - indexed for MEDLINE]
12.

Cyclosporine a loaded solid lipid nanoparticles: optimization of formulation, process variable and characterization.

Varia JK, Dodiya SS, Sawant KK.

Curr Drug Deliv. 2008 Jan;5(1):64-9.

PMID:
18220553
[PubMed - indexed for MEDLINE]
13.

Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.

Suresh G, Manjunath K, Venkateswarlu V, Satyanarayana V.

AAPS PharmSciTech. 2007 Mar 23;8(1):24.

PMID:
17408223
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Enhancement the oral bioavailability of praziquantel by incorporation into solid lipid nanoparticles.

Yang L, Geng Y, Li H, Zhang Y, You J, Chang Y.

Pharmazie. 2009 Feb;64(2):86-9.

PMID:
19320279
[PubMed - indexed for MEDLINE]
15.

Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.

Aji Alex MR, Chacko AJ, Jose S, Souto EB.

Eur J Pharm Sci. 2011 Jan 18;42(1-2):11-8. doi: 10.1016/j.ejps.2010.10.002. Epub 2010 Oct 29.

PMID:
20971188
[PubMed - indexed for MEDLINE]
16.

Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.

Garg A, Singh S.

Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):280-8. doi: 10.1016/j.colsurfb.2011.05.030. Epub 2011 May 26.

PMID:
21689909
[PubMed - indexed for MEDLINE]
17.

Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.

Rawat MK, Jain A, Singh S.

J Pharm Sci. 2011 Jun;100(6):2366-78. doi: 10.1002/jps.22435. Epub 2011 Jan 5.

PMID:
21491449
[PubMed - indexed for MEDLINE]
18.

Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.

Dudhipala N, Veerabrahma K.

Drug Deliv. 2014 May 28:1-10. [Epub ahead of print]

PMID:
24865287
[PubMed - as supplied by publisher]
19.

Enhancement of intestinal permeability utilizing solid lipid nanoparticles increases γ-tocotrienol oral bioavailability.

Abuasal BS, Lucas C, Peyton B, Alayoubi A, Nazzal S, Sylvester PW, Kaddoumi A.

Lipids. 2012 May;47(5):461-9. doi: 10.1007/s11745-012-3655-4. Epub 2012 Jan 24.

PMID:
22271424
[PubMed - indexed for MEDLINE]
20.

Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles.

Zhu RR, Qin LL, Wang M, Wu SM, Wang SL, Zhang R, Liu ZX, Sun XY, Yao SD.

Nanotechnology. 2009 Feb 4;20(5):055702. doi: 10.1088/0957-4484/20/5/055702. Epub 2009 Jan 12.

PMID:
19417361
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk